Evidence map›Paper›PMID 27528047›Full record

ArticleMolecular and cellular biochemistry2016

Trans-cinnamaldehyde protected PC12 cells against oxygen and glucose deprivation/reperfusion (OGD/R)-induced injury via anti-apoptosis and anti-oxidative stress.

Xue Qi, Ru Zhou, Yue Liu, Jing Wang, Wan-Nian Zhang, Huan-Ran Tan, Yang Niu, Tao Sun, Yu-Xiang Li, Jian-Qiang Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Mechanism of miR-218-5p in autophagy, apoptosis and oxidative stress in rheumatoid arthritis synovial fibroblasts is mediated by KLF9 and JAK/STAT3 pathways.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021
    Article
  5. Article
  6. Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xue QiDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China.
Ru ZhouDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China.
Yue LiuDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China.
Jing WangDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China.
Wan-Nian ZhangDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China.
Huan-Ran TanDepartment of Pharmacology, Peking University, Health Science Center, Beijing, 100191, People's Republic of China.
Yang NiuKey Laboratory of Hui Ethnic Medicine Modernization, Ministry of Education, Ningxia Medical University, Ningxia Hui Autonomous Region, Yinchuan, 750004, People's Republic of China.
Tao SunNingxia Key Laboratory of Craniocerebral Diseases of Ningxia Hui Autonomous Region, Ningxia Medical University, Ningxia Hui Autonomous Region, 750004, Yinchuan, People's Republic of China.
Yu-Xiang LiDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China. li_yuxiang@163.com.
Jian-Qiang YuDepartment of Pharmacology, Ningxia Medical University, Ningxia Hui Autonomous Region, 1160 Shengli Street, Yinchuan, 750004, People's Republic of China. yujq910315@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia stroke is the major cause of mortality and permanent neurological disability with little definitive therapeutic options. This cerebral ischemic injury leads to the oxidative stress and eventually cell death. We hypothesized that treatment of this condition with the trans-cinnamaldehyde(TC) could protect cells from ischemic and reperfusion injury. Oxygen and glucose deprivation/reperfusion (OGD/R) was used as an in vitro model of hypoxic ischemic injury in present study. MTT was used to evaluate the protective effects of TC. Next, we tested whether TC reduced the production of reactive oxygen species (ROS). Besides, experiments were performed to determine whether or not the mitochondrial membrane potential was affected. Furthermore, the inhibiters of NO and PI3 K were used to determine the initial mechanisms. TC treatment improved cell viability, reduced intracellular ROS, and increased MMP. Further, the inhibition of NO or PI3 K significantly reduced TC's protective effects. These findings suggest that TC might be a promising agent for ischemic stroke.

Indexed as

AcroleinAnimalsApoptosisGlucoseOxidative StressOxygenPC12 CellsRatsReactive Oxygen SpeciesReperfusion InjuryAcroleincinnamaldehydeGlucoseOxygenReactive Oxygen SpeciesApoptosisIschemic injuryOxidative stressOxygen and glucose deprivationPC12 cellsTrans-cinnamaldehyde

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.